Wednesday, December 31, 2025
ADVT 
National

No unexpected effects from COVID-19 shots so far

Darpan News Desk The Canadian Press, 08 Jan, 2021 06:26 PM
  • No unexpected effects from COVID-19 shots so far

Health Canada has no reports of unexpected side-effects from patients vaccinated against COVID-19 thus far.

"There haven't been any serious adverse events, or even the mild and moderate adverse events, that have been out of line or different than what we've seen in the clinical trials," Dr. Supriya Sharma said in an interview with The Canadian Press Friday.

Sharma, Health Canada's chief medical adviser, is overseeing the vaccine review process.

She said experts look for two things when reviewing data after vaccines are given. The first is whether anything happens that was not observed during the clinical trials, and the second is whether the side-effects that were documented during the trials are more severe or greater in number than what the trials saw.

The answer to both questions in Canada so far is no, said Sharma.

"It seems that the clinical trials are pretty representative," she said.

The most common side-effects from the vaccines are short-term fever, pain at the injection site, headache and fatigue. Most subside within 24 hours.

Health Canada approved two vaccines for COVID-19 in December, including one from Pfizer and BioNTech and a second from Moderna.

Vaccinations began Dec. 14, and data aggregated by University of Saskatchewan student Noah Little shows about 230,000 doses have been given so far. Most of the first doses went to front-line hospital staff and long-term care workers and a smaller number of long-term care residents.

Vaccines began reaching some First Nations and northern territories this week.

Health Canada continues to review data from two other vaccine developers, AstraZeneca and Johnson & Johnson, but is still awaiting more data from the companies. Sharma said she can't say when Health Canada would be ready to make a decision about either one.

Both companies are expected to complete Phase 3 clinical trials in the United States this month.

MORE National ARTICLES

Family of police shooting victim seeks answers

Family of police shooting victim seeks answers
The silence inside the Campbells' home west of Toronto has grown like a cancer in the weeks since April 6.

Family of police shooting victim seeks answers

No PMO direction to choose WE: minister

No PMO direction to choose WE: minister
The federal youth minister says she was not directed by the Prime Minister Justin Trudeau's office to make an agreement with WE Charity to run a federal volunteering program, a deal that has since been aborted and mired in ethical questions.

No PMO direction to choose WE: minister

Ashton College - Live Online Education to Fit Your Career Goals

Ashton College - Live Online Education to Fit Your Career Goals
It is the focus on helping students be career-ready that has made Ashton College such a highly sought out school.

Ashton College - Live Online Education to Fit Your Career Goals

Navy to drop 'seaman' for gender-neutral term

Navy to drop 'seaman' for gender-neutral term
The Canadian military's sailors and the public will have a chance to weigh in as the Royal Canadian Navy moves to drop the term "seaman" when referring to its most junior sailors and replace it with something more gender-neutral.

Navy to drop 'seaman' for gender-neutral term

Quebec firm caught making illegal donations

Quebec firm caught making illegal donations
Canada's elections watchdog says a Quebec engineering firm illegally donated more than $46,000 to federal political entities over a period of seven years.

Quebec firm caught making illegal donations

Canada-U.S. travel ban extended: DHS

Canada-U.S. travel ban extended: DHS
The U.S. Department of Homeland Security says Canada and the United States have agreed to extend their mutual ban on non-essential travel between the two countries until Aug.20.

Canada-U.S. travel ban extended: DHS